TABLE 3.
In vivo blockade of C5a after CLP
1. | Improved survival |
2. | Reduced loss of innate immune function of blood PMNs |
3. | Alleviation of the cardiomyopathy of sepsis |
4. | Greatly diminished apoptosis of thymocytes |
5. | Attenuation of consumptive coagulopathy of sepsis |